Web Stats Provided By Google Analytics

Wednesday, November 15, 2017

Drugmaker Acorda Plunges After Deaths in Parkinson's Trial

... U.S. regulators said they wouldn't review Acorda's application to sell Inbrija because of questions about the Ardsley, New York-based company's manufacturing. On the call, Cohen said the company plans to resubmit a new drug application for Inbrija ...
http://ift.tt/2zEdiMt

No comments:

Post a Comment

Popular Ardsley Roundup Posts